Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.13.638029

Staphylococcal Internalization into Osteoblasts: A Partially Conserved Mechanism Across the Genus

Abstract

Staphylococcus aureus, considered as a major human pathogen, is associated with severe infections such as bacteremia, endocarditis, skin and soft tissue infections, and bone and joint infections. Virulence mechanisms, such as biofilm formation and invasion/internalization of/into host cells, support the pathogenicity of S. aureus as they enable it to evade from the immune system and most antibiotic treatments. S. aureus can be internalized into non-professional phagocytic cells like fibroblasts, epithelial cells, endothelial cells and osteoblasts. The main pathway of internalization of S. aureus is FnBP-fibronectin-5{beta}1 integrin dependent. Interestingly, S. pseudintermedius, S. delphini and S. argenteus are able to invade osteoblasts, depending on the presence of FnBP-like proteins such as Staphylococcus pseudintermedius surface proteins D and L (SpsD/L) or Staphylococcus delphini surface protein Y (SdsY). However, the internalization capacity and mechanism have been poorly investigated in other staphylococci species. Here, we investigated the internalization capacity of staphylococci into osteoblasts at the genus level and attempted to correlate it with the presence of FnBP-like proteins by combining fibronectin adhesion assays, infection of osteoblasts and genome analysis. Over the 53 Staphylococcus species tested, half of them exhibited high internalization into osteoblasts. We highlighted that the "FnBP-fibronectin-5{beta}1 integrin" dependent internalization pathway of S. aureus, is well-conserved in 27 Staphylococcus species. In silico analysis identified multiple FnBP-like proteins correlating with the highly internalized species and showing diversity in their sequence organization, likely due to multiple acquisitions of such encoding genes throughout Staphylococcus evolution. AUTHOR SUMMARYStaphylococcus aureus is a pathogenic bacterium that causes severe infections including bone and joint infections. It invades bone cells, such as osteoblasts, using the bacterial surface protein FnBP, which binds to fibronectin, an extracellular compound, which subsequently binds to 5{beta}1 integrin on the surface of osteoblasts. This cross-linking enables active internalization of S. aureus by the cells and potential intracellular persistence, which are responsible for the ability to induce staphylococcal chronic infections. While four species have been studied for their internalization into osteoblasts, a comprehensive genus-level investigation remains unexplored. Therefore, we investigated the conservation of this internalization capacity among the genus Staphylococcus, including a significant number of species of animal origin. Approximately half of the genus is capable of invading osteoblasts at varying levels via 5{beta}1 integrin. Additionally, homologous proteins to FnBP were identified in most highly internalized species, suggesting a similar pathway of cell internalization to that of S. aureus. Genomic analysis reveals these proteins were acquired multiple times during evolution, suggesting they provide an advantage for host infection. In the context of One Health approach and the increasing number of animal pathogens causing human infections, understanding staphylococcal pathogenicity will help anticipate the emergence of new infectious diseases.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Crepin, D. M., Bonhomme, M., Faure, A., Sinel, C., Bergot, M., Dyon-Tafani, V., Maali, Y., Bouvard, D., Diot, A., Laurent, F., Josse, J.. 2025-02-13. Staphylococcal Internalization into Osteoblasts: A Partially Conserved Mechanism Across the Genus. https://doi.org/10.1101/2025.02.13.638029

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗